Analyst Reco. Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-11 pm EDT			5-day change	1st Jan Change
5.85 ^USD	+1.74%		+7.73%	-54.12%

May. 29	Treace Medical Concepts Insider Bought Shares Worth $253,475, According to a Recent SEC Filing	MT
May. 17	North American Morning Briefing : The "Everything -2-	DJ

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Treace Medical Concepts Insider Bought Shares Worth $253,475, According to a Recent SEC Filing	May. 29	MT
UBS Downgrades Treace Medical Concepts to Neutral From Buy, Cuts Price Target to $6.50 From $16	May. 16	MT
UBS Adjusts Price Target on Treace Medical Concepts to $16 From $17, Maintains Buy Rating	May. 08	MT
Truist Downgrades Treace Medical Concepts to Hold From Buy, Cuts PT to $7 From $17; Notes Slowing Growth Outlook Amid Rising Competitive Pressures	May. 08	MT
Truist Securities Downgrades Treace Medical Concepts to Hold From Buy, Lowers Price Target to $7 From $17	May. 08	MT
BTIG Downgrades Treace Medical Concepts to Neutral From Buy	May. 08	MT
JPMorgan Downgrades Treace Medical Concepts to Neutral From Overweight, Cuts Price Target to $8 From $15	May. 08	MT
Stifel Downgrades Treace Medical Concepts to Hold From Buy, Cuts Price Target to $6 From $15	May. 08	MT
Truist Securities Adjusts Price Target on Treace Medical Concepts to $16 From $12, Keeps Buy Rating	Dec. 22	MT
UBS Adjusts Price Target on Treace Medical Concepts to $17 From $24, Maintains Buy Rating	Nov. 13	MT
Morgan Stanley Adjusts Price Target on Treace Medical Concepts to $14 From $30, Maintains Overweight Rating	Nov. 13	MT
Truist Adjusts Price Target on Treace Medical Concepts to $12 From $17, Maintains Buy Rating	Nov. 10	MT
UBS Initiates Treace Medical Concepts With Buy Rating, Price Target is $24	23-09-29	MT
BTIG Adjusts Treace Medical Concepts' Price Target to $27.50 From $32, Keeps Buy Rating	23-08-28	MT
Stephens Adjusts Price Target on Treace Medical Concepts to $25 From $27, Keeps Equalweight Rating	23-08-10	MT
Truist Securities Adjusts Price Target on Treace Medical Concepts to $30 From $33, Maintains Buy Rating	23-08-09	MT
Truist Starts Treace Medical Concepts at Buy With $33	23-05-01	MT
BTIG Adjusts Price Target on Treace Medical Concepts to $32 From $29, Maintains Buy Rating	23-04-17	MT
Stephens Starts Treace Medical Concepts at Equalweight With $26 Price Target	23-04-11	MT
Morgan Stanley Adjusts Price Target on Treace Medical Concepts to $30 From $28, Maintains Overweight Rating	23-03-08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Analyst Reco.

Filters